XFRA CAPITAL ADJUSTMENT INFORMATION

XFRA CAPITAL ADJUSTMENT INFORMATION - 02.07.2025

Das Instrument 3MM FR0013296746 ADVICENNE (PROM.) EO-,20 EQUITY wird ex Kapitalmassnahme gehandelt am 02.07.2025
The instrument 3MM FR0013296746 ADVICENNE (PROM.) EO-,20 EQUITY is traded ex capital adjustment on 02.07.2025

Das Instrument JHA0 US47030M1062 JAMES HARDIE INDUST.ADR/1 EQUITY wird ex Kapitalmassnahme gehandelt am 02.07.2025
The instrument JHA0 US47030M1062 JAMES HARDIE INDUST.ADR/1 EQUITY is traded ex capital adjustment on 02.07.2025

Das Instrument AC6 SE0010133785 ALZECURE PHARMA AB EQUITY wird cum Kapitalmassnahme gehandelt am 02.07.2025 und ex Kapitalmassnahme am 03.07.2025
The instrument AC6 SE0010133785 ALZECURE PHARMA AB EQUITY is traded cum capital adjustment on 02.07.2025 and ex capital adjustment on 03.07.2025

Das Instrument CVY CA1787181025 CITY VIEW GREEN HOLDINGS EQUITY wird cum Kapitalmassnahme gehandelt am 02.07.2025 und ex Kapitalmassnahme am 03.07.2025
The instrument CVY CA1787181025 CITY VIEW GREEN HOLDINGS EQUITY is traded cum capital adjustment on 02.07.2025 and ex capital adjustment on 03.07.2025

Zeitenwende! 3 Uranaktien vor der Neubewertung

Ende Mai leitete US-Präsident Donald Trump mit der Unterzeichnung mehrerer Dekrete eine weitreichende Wende in der amerikanischen Energiepolitik ein. Im Fokus: der beschleunigte Ausbau der Kernenergie.

Mit einem umfassenden Maßnahmenpaket sollen Genehmigungsprozesse reformiert, kleinere Reaktoren gefördert und der Anteil von Atomstrom in den USA massiv gesteigert werden. Auslöser ist der explodierende Energiebedarf durch KI-Rechenzentren, der eine stabile, CO₂-arme Grundlastversorgung zwingend notwendig macht.

In unserem kostenlosen Spezialreport erfahren Sie, welche 3 Unternehmen jetzt im Zentrum dieser energiepolitischen Neuausrichtung stehen, und wer vom kommenden Boom der Nuklearindustrie besonders profitieren könnte.

Holen Sie sich den neuesten Report! Verpassen Sie nicht, welche Aktien besonders von der Energiewende in den USA profitieren dürften, und laden Sie sich das Gratis-PDF jetzt kostenlos herunter.

Dieses exklusive Angebot gilt aber nur für kurze Zeit! Daher jetzt downloaden!

Hier klicken

Zeit	Aktuelle Nachrichten
Mi	XFRA CAPITAL ADJUSTMENT INFORMATION - 02.07.2025	Das Instrument 3MM FR0013296746 ADVICENNE (PROM.) EO-,20 EQUITY wird ex Kapitalmassnahme gehandelt am 02.07.2025 The instrument 3MM FR0013296746 ADVICENNE (PROM.) EO-,20 EQUITY is traded ex capital... ► Artikel lesen
Mo	Advicenne Confirms the Upcoming Filing for Registration of ADV7103 in the USA and is Securing Its Financing Through Loan Restructuring and the Launch of a Rights Issue.	Submission of the US marketing authorization application for ADV7103 planned in Q4 2025, following positive feedback from the FDA on the additional data submitted. Repayment of tranches... ► Artikel lesen
29.04.	ADVICENNE: Advicenne met à disposition son Document d'Enregistrement Universel 2024
29.04.	Advicenne 2024 Universal Registration Document Made Available	Regulatory News: Advicenne (Euronext Growth Paris ALDVI FR0013296746), a specialty pharmaceutical company dedicated to the development and commercialization of innovative treatments for those suffering... ► Artikel lesen
27.03.	Advicenne: Fiscal Year 2024 Marked by the Satisfactory Commercial Performance of Sibnayal in Europe and Development in the United States	Total product sales of Advicenne up 9.4% to €4.9m Operating cash consumption below €1M by 2025 and significant improvement in cash flow Cash position of €3.2 million on December... ► Artikel lesen

Zeit

Aktuelle Nachrichten

XFRA CAPITAL ADJUSTMENT INFORMATION - 02.07.2025

Advicenne Confirms the Upcoming Filing for Registration of ADV7103 in the USA and is Securing Its Financing Through Loan Restructuring and the Launch of a Rights Issue.

Submission of the US marketing authorization application for ADV7103 planned in Q4 2025, following positive feedback from the FDA on the additional data submitted. Repayment of tranches...
► Artikel lesen

29.04.

ADVICENNE: Advicenne met à disposition son Document d'Enregistrement Universel 2024

29.04.

Advicenne 2024 Universal Registration Document Made Available

Regulatory News: Advicenne (Euronext Growth Paris ALDVI FR0013296746), a specialty pharmaceutical company dedicated to the development and commercialization of innovative treatments for those suffering...
► Artikel lesen

27.03.

Advicenne: Fiscal Year 2024 Marked by the Satisfactory Commercial Performance of Sibnayal in Europe and Development in the United States

Total product sales of Advicenne up 9.4% to €4.9m Operating cash consumption below €1M by 2025 and significant improvement in cash flow Cash position of €3.2 million on December...
► Artikel lesen

Zeit	Aktuelle Nachrichten
Mi	The Extraordinary General Meeting of AlzeCure Pharma AB Approved the Decision on the New Issue of Shares	STOCKHOLM, SE / ACCESS Newswire / July 2, 2025 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) - At an extraordinary general meeting in AlzeCure Pharma AB on July 2, 2025, the shareholders decided to approve... ► Artikel lesen
Mi	XFRA CAPITAL ADJUSTMENT INFORMATION - 02.07.2025	Das Instrument 3MM FR0013296746 ADVICENNE (PROM.) EO-,20 EQUITY wird ex Kapitalmassnahme gehandelt am 02.07.2025 The instrument 3MM FR0013296746 ADVICENNE (PROM.) EO-,20 EQUITY is traded ex capital... ► Artikel lesen
17.06.	AlzeCure Pharma: AlzeCure Receives an Additional Subscription Commitment of Approximately SEK 5 million in the Upcoming Rights Issue	NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, WITHIN OR INTO THE RUSSIAN FEDERATION, BELARUS, AUSTRALIA, HONGKONG, JAPAN, CANADA, NEW ZEALAND, SWITZERLAND... ► Artikel lesen
16.06.	Notice To Extraordinary General Meeting In Alzecure Pharma AB	STOCKHOLM, SE / ACCESS Newswire / June 16, 2025 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) - The shareholders of AlzeCure Pharma AB are hereby summoned to an extraordinary general meeting to be held on... ► Artikel lesen
16.06.	AlzeCure Pharma: AlzeCure Carries out a Rights Issue of Approximately SEK 48.5 million	NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, WITHIN OR INTO THE RUSSIAN FEDERATION, BELARUS, AUSTRALIA, HONGKONG, JAPAN, CANADA, NEW ZEALAND, SWITZERLAND... ► Artikel lesen

Zeit

Aktuelle Nachrichten

The Extraordinary General Meeting of AlzeCure Pharma AB Approved the Decision on the New Issue of Shares

STOCKHOLM, SE / ACCESS Newswire / July 2, 2025 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) - At an extraordinary general meeting in AlzeCure Pharma AB on July 2, 2025, the shareholders decided to approve...
► Artikel lesen

XFRA CAPITAL ADJUSTMENT INFORMATION - 02.07.2025

17.06.

AlzeCure Pharma: AlzeCure Receives an Additional Subscription Commitment of Approximately SEK 5 million in the Upcoming Rights Issue

NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, WITHIN OR INTO THE RUSSIAN FEDERATION, BELARUS, AUSTRALIA, HONGKONG, JAPAN, CANADA, NEW ZEALAND, SWITZERLAND...
► Artikel lesen

16.06.

Notice To Extraordinary General Meeting In Alzecure Pharma AB

STOCKHOLM, SE / ACCESS Newswire / June 16, 2025 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) - The shareholders of AlzeCure Pharma AB are hereby summoned to an extraordinary general meeting to be held on...
► Artikel lesen

16.06.

AlzeCure Pharma: AlzeCure Carries out a Rights Issue of Approximately SEK 48.5 million

Zeit	Aktuelle Nachrichten
00:01	XFRA NEW INSTRUMENTS AVAILABLE ON 03.07.2025	The following instruments on XETRA do have their first trading 03.07.2025 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 03.07.2025 Aktien 1 IE000R94NGM2 James Hardie Industries... ► Artikel lesen
Mi	XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 02.07.2025	The following instruments on Boerse Frankfurt do have their last trading day on 02.07.2025Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 02.07.2025ISIN NameBMG3075P1014 ENSTAR... ► Artikel lesen
Mi	XFRA ISIN CHANGE	Einstellung Aufnahme ISIN Name Einstellung mit Ablauf: ISIN Name Ab dem: AnmerkungenCA1787181025 City View Green Holdings Inc. 02.07.2025 CA1787182015 City View Green Holdings Inc. 03.07.2025 Tausch... ► Artikel lesen
Mi	XFRA CAPITAL ADJUSTMENT INFORMATION - 02.07.2025	Das Instrument 3MM FR0013296746 ADVICENNE (PROM.) EO-,20 EQUITY wird ex Kapitalmassnahme gehandelt am 02.07.2025 The instrument 3MM FR0013296746 ADVICENNE (PROM.) EO-,20 EQUITY is traded ex capital... ► Artikel lesen
Di	City View Green Holdings Inc: City View Green 1:10 rollback

Zeit

Aktuelle Nachrichten

00:01

XFRA NEW INSTRUMENTS AVAILABLE ON 03.07.2025

The following instruments on XETRA do have their first trading 03.07.2025 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 03.07.2025 Aktien 1 IE000R94NGM2 James Hardie Industries...
► Artikel lesen

XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 02.07.2025

The following instruments on Boerse Frankfurt do have their last trading day on 02.07.2025Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 02.07.2025ISIN NameBMG3075P1014 ENSTAR...
► Artikel lesen

XFRA ISIN CHANGE

Einstellung Aufnahme ISIN Name Einstellung mit Ablauf: ISIN Name Ab dem: AnmerkungenCA1787181025 City View Green Holdings Inc. 02.07.2025 CA1787182015 City View Green Holdings Inc. 03.07.2025 Tausch...
► Artikel lesen

XFRA CAPITAL ADJUSTMENT INFORMATION - 02.07.2025

City View Green Holdings Inc: City View Green 1:10 rollback

Unternehmen / Aktien	Kurs	%
ADVICENNE	1,344	-2,18 %
ALZECURE PHARMA AB	0,219	-4,37 %
CITY VIEW GREEN HOLDINGS INC	-	-

Unternehmen / Aktien

Kurs

ADVICENNE

1,344

-2,18 %

ALZECURE PHARMA AB

0,219

-4,37 %

CITY VIEW GREEN HOLDINGS INC

	Indizes	Kurs	%	News 24 h / 7 T	Aufrufe 7 Tage


	Aktien	Kurs	%	News 24 h / 7 T	Aufrufe 7 Tage


	Xetra-Orderbuch


	Fonds	Kurs	%


	Devisen	Kurs	%


	Rohstoffe	Kurs	%


	Themen	Kurs	%



Erweiterte Suche